Huntingtons Disease Therapeutics Market
- 2026 年市場規模
- USD 6,608.4 Mn
- 2033 年預估規模
- USD 21,751.3 Mn
- 年複合成長率 CAGR
- 18.6%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Huntingtons Disease Therapeutics Market, By Drug Class (Vesicular Monoamine Transporter Inhibitors, Monoamine Depletors, Anticonvulsants, Antidepressants, Antipsychotics, and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global Huntington’s disease therapeutics market is estimated to be valued at USD 6,608.4 Mn in 2026 and is expected to reach USD 21,751.3 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 18.6% from 2026 to 2033. Huntington's disease is a rare, inherited neurological disorder resulting in progressively impaired movement, cognitive impairment and psychiatric symptoms. The market includes both existing approved symptomatic treatments and an increasing number of disease-modifying therapies including gene therapies, RNA-targeting therapies and new neurological approaches.
The growth in the market is due to increasing awareness and diagnosis of the disorder, rapid advancement in genetic testing and increased investment in neuroscience research and development. Additionally, a robust pipeline of development, beneficial orphan drug policies, and the development of second-generation therapies are contributing to accelerating innovations in the treatment field and therefore growth is anticipated to be significant long term as the pharmaceutical and biotech companies continue to develop and bring new treatments, designed to slow or alter disease progression to market.
Market Dynamics
The global Huntington’s disease therapeutics market is driven by rising awareness regarding Huntington's disease, sophisticated gene testing, and increased funding in the neurodegenerative diseases sector. The market is rapidly gaining momentum on the back of developing gene therapies, RNA targeted drugs, and other disease modifying therapies that target the root cause of Huntington's disease. Strong incentives for orphan drugs and widening clinical trial activities further augment therapeutic development and market growth.
However, a number of constraints are present in the market, such as high costs associated with novel therapies, complicated clinical development pathways and the relatively smaller patient pool inherent in the treatment of rare disorders. Regulatory unpredictability associated with novel gene-based therapies and challenges in proving long-term treatment effects may hamper market adoption. Nevertheless, the steady progress in the realm of precision medicine, robust growth in collaborations between biotech and research organizations and a promising pipeline at a late stage will lead to robust opportunities.
Key Features of the Study
• This report provides in-depth analysis of the global Huntington’s disease therapeutics market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Huntington’s disease therapeutics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Roche Holding AG, Novartis AG, uniQure N.V., Wave Life Sciences Ltd., PTC Therapeutics, Inc., Prilenia Therapeutics B.V., Neurocrine Biosciences, Inc., Teva Pharmaceutical Industries Ltd., Sage Therapeutics, Inc., and Voyager Therapeutics, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Huntington’s disease therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Huntington’s disease therapeutics market
Market Segmentation
• Drug Class Insights (Revenue, USD Mn, 2021 - 2033)
o Vesicular Monoamine Transporter Inhibitors
o Monoamine Depletors
o Anticonvulsants
o Antidepressants
o Antipsychotics
o Others
• Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
o Oral
o Parenteral
• Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Roche Holding AG
o Novartis AG
o uniQure N.V.
o Wave Life Sciences Ltd.
o PTC Therapeutics, Inc.
o Prilenia Therapeutics B.V.
o Neurocrine Biosciences, Inc.
o Teva Pharmaceutical Industries Ltd.
o Sage Therapeutics, Inc.
o Voyager Therapeutics, Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Huntington’s Disease Therapeutics Market, By Drug Class
Global Huntington’s Disease Therapeutics Market, By Route of Administration
Global Huntington’s Disease Therapeutics Market, By Distribution Channel
Global Huntington’s Disease Therapeutics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Industry Trends
4. Global Huntington’s Disease Therapeutics Market, By Drug Class, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Vesicular Monoamine Transporter Inhibitors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Monoamine Depletors
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Anticonvulsants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Antidepressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Antipsychotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Huntington’s Disease Therapeutics Market, By Route of Administration, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Parenteral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Huntington’s Disease Therapeutics Market, By Distribution Channel, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Huntington’s Disease Therapeutics Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
8. Competitive Landscape
o Roche Holding AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o uniQure N.V.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Wave Life Sciences Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o PTC Therapeutics, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Prilenia Therapeutics B.V.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Neurocrine Biosciences, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sage Therapeutics, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Voyager Therapeutics, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
10. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on ‘Huntington’s Disease Therapeutics Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們